Mankind Pharma Limited has informed the Exchange about General Updates
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has been assigned an ESG rating of 'B' by MSCI ESG Ratings and Research Private Limited. The company received the ESG report on November 4, 2025, and clarified that MSCI issued the rating independently — the company did not engage MSCI for this assessment. The disclosure was made under SEBI Listing Regulations 30 and 51, and the full report has also been uploaded to the company's website.
This is a routine ESG disclosure with no direct impact on earnings, operations, or stock price. A 'B' rating from MSCI is on the lower end of the scale (AAA to CCC), which investors monitoring ESG metrics should note but is unlikely to materially move the stock.